China Studies Centre, the University of Sydney
5:00-7:00pm, Thursday 8 March
Lecture Room 1, Business School CBD Campus, Level 17, Stockand Building
133 Castlereagh Street, Sydney, NSW 2000
Chinese investment in Australia’s healthcare sector has surged over the past years, reaching a total of AUD $5.5 billion across 16 completed deals within a short three years.
The latest report from KPMG and The University of Sydney Business School Demystifying Chinese Investment in Australian Healthcare found that Chinese investment in Australian healthcare has been concentrated in the health supplement and medical treatment sectors in Australia. Remarkably, this investment is targeting the Chinese domestic market and shows that Australian health care services are world leading and have huge scope for expansion in China and Asia.
Join us for the launch and hear from the key researchers of this report.
Panel chair: Natalie Cope, Chief Executive Officer of the Australia China Business Council (NSW Branch)
Panellists: Dr Selina Lo, Medical doctor and senior editor at The Lancet
Dr Wei Li, Lecturer in International Business, the University of Sydney Business School
Professor Hans Hendrischke, Professor of Chinese Business and Management at the University of Sydney Business School